Edelman Joseph's Form 4 filing
Verrica Pharmaceuticals Inc. (VRCA) · filed Dec 29, 2023
- Accession no.
- 0001062993-23-023292
- Filed
- Dec 29, 2023, 5:27 PM ET
- Trade date
- Dec 27-29, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $2.31M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edelman JosephCIK 0001164426 | 10% Owner |
| Perceptive Advisors LLCCIK 0001224962 | 10% Owner |
| Perceptive Life Sciences Master Fund LtdCIK 0001249675 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 27, 2023 | Common Stock | PPurchaseAcquired | +79,726 | $7.20 | +$574,027.2 | 6,857,292 | Indirect | |
| Dec 28, 2023 | Common Stock | PPurchaseAcquired | +126,116 | $7.08 | +$892,901.28 | 6,983,408 | Indirect | |
| Dec 29, 2023 | Common Stock | PPurchaseAcquired | +115,774 | $7.24 | +$838,203.76 | 7,099,182 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.